<DOC>
	<DOCNO>NCT02049450</DOCNO>
	<brief_summary>Patients severe thalassemia ( thalassemia major ) present severe anemia require life-long transfusion therapy , spleen enlargement may lead increased transfusion requirement , serious complication early death , growth retardation , bone deformation iron overload due blood transfusion . Splenectomy significantly reduce transfusion requirement thalassemia patient , associate increase risk serious complication sepsis thrombosis . Preliminary preclinical clinical data suggest JAK2 inhibition , reduce spleen size , may improve hemoglobin level , thereby eliminate need splenectomy reduce transfusion requirement relate iron overload .</brief_summary>
	<brief_title>Study Efficacy Safety INC424 Regularly Transfused Patients With Thalassemia .</brief_title>
	<detailed_description />
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>beta-Thalassemia</mesh_term>
	<criteria>1 . Patients 18 year age old 2 . Patients thalassemia regular stable transfusion regimen ( least 2 RBC unit within every 4week interval 24 week prior Screening ) anticipate receive transfusion regimen study . 3 . Patients spleen enlargement Screening , define spleen palpable costal margin spleen volume ≥ 450 cm3 confirm MRI ( CT scan applicable patient ) . 4 . Patients need iron chelation treatment ( deferoxamine deferasirox ) least four week prior Screening 1 . Splenectomy prior plan study . 2 . Active serious bacterial , mycobacterial , fungal , parasitic viral infection require therapy ( e.g. , pneumonia , tuberculosis , systemic mycosis , herpes zoster ) . 3 . Hemoglobin &lt; 65 g/L ( &lt; 4.0 mmol/L ) Screening . 4 . Platelet count &lt; 75×109/L , absolute neutrophil count &lt; 1.5×109/L Screening . 5 . Estimated MDRD &lt; 30 mL/min/1.73 m2 Screening . 6 . ALT ( SGPT ) level &gt; 5 time ULN Screening . 7 . Hepatocellular disease hepatitis B ( presence HBs antigen ) , hepatitis C ( presence HCV RNA ) , liver cirrhosis . 8 . HIV positivity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>thalassemia , spleen enlargement</keyword>
</DOC>